Skip to main content
. 2013 Jul 14;24(10):2601–2606. doi: 10.1093/annonc/mdt249

Table 2.

National Cancer Institute Common Toxicity Criteria for Adverse Events Grade 3 and 4 treatment-related adverse events in the phase ii study population (n=19)

Number of patients
No. of events by grade
Adverse event No. % Grade 3 Grade 4
Neutropenia 9 47 7 2
Anemia 2 11 2 0
Lymphopenia 9 47 8 1
Leucopenia 2 11 1 1
Hyperuricemia 1 5 0 1
Hypokalemia 1 5 1 0
Vomiting 1 5 1 0
Upper respiratory infection 1 5 1 0
Vascular access complication 2 10 2 0